US Stock MarketDetailed Quotes

RIGL Rigel Pharmaceuticals

Watchlist
  • 20.130
  • +2.780+16.02%
Close Jan 17 16:00 ET
  • 19.870
  • -0.260-1.29%
Post 20:01 ET
354.59MMarket Cap74.56P/E (TTM)

Rigel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rigel Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 44.693M--
--2024/Q4-- / 57.585M--
Nov 7, 20242024/Q355.307M / 41.934M--
Aug 6, 20242024/Q236.841M / 33.704M--
May 7, 20242024/Q129.534M / 31.472M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 44.693M--
--2024/Q4-- / 57.585M--
Nov 7, 20242024/Q355.307M / 41.934M--
Aug 6, 20242024/Q236.841M / 33.704M--
May 7, 20242024/Q129.534M / 31.472M--

Unlock Free Earnings Estimates

Rigel Pharmaceuticals Earnings Reports

  • Rigel Pharmaceuticals | 8-K: Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 7, 2024 16:29 ET

  • Rigel Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 16:14 ET

  • Rigel Pharmaceuticals | 8-K: Press Release, dated August 6, 2024, titled “Rigel Reports Second Quarter 2024 Financial Results and Provides Business Update.”

    Aug 6, 2024 16:15 ET

  • Rigel Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 6, 2024 16:09 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 20, 2025

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-0.79%